Avamis (fluticasone furoate) nasal spray 27.5 mcg/dose 30 doses №1

$15.30

Manufacturer: GreatBritain

Purpose: Reduces inflammation in nasal passages to treat allergic rhinitis symptoms.

SKU: MED56703 Category:

Description

Avamis (fluticasone furoate) nasal spray 27.5 mcg/dose 30 doses №1

Ingredients

Active ingredient: Fluticasone furoate. Other ingredients include microcrystalline cellulose, carboxymethylcellulose sodium, dextrose, polysorbate 80, purified water, and benzalkonium chloride.

Dosage

Recommended dosage: The usual dose is 2 sprays in each nostril once daily. Do not exceed the recommended dose.

Indications

Avamis nasal spray is indicated for the treatment of symptoms of allergic rhinitis in adults and children aged 2 years and older.

Contraindications

Do not use Avamis nasal spray if you are allergic to fluticasone furoate or any other ingredients in the product.

Directions

Directions for use: Shake gently before each use. Prime the spray pump before the first use. Insert the nozzle into one nostril while closing the other nostril. Press down on the pump to release the spray while breathing in gently through the nose.

Scientific Evidence

Studies have shown that fluticasone furoate, the active ingredient in Avamis nasal spray, has potent anti-inflammatory effects in the nasal mucosa. It helps reduce nasal congestion, sneezing, itching, and runny nose associated with allergic rhinitis.

Additional Information

Storage: Store at room temperature away from moisture and heat. Keep the bottle tightly closed when not in use. Warnings: Avoid spraying into your eyes. If irritation or sensitivity occurs, discontinue use and consult a healthcare provider.

Fluticasone furoate, the active ingredient in Avamis nasal spray, belongs to a class of medications known as corticosteroids. It works by reducing inflammation in the nasal passages, thereby relieving symptoms of allergic rhinitis. Unlike oral corticosteroids, nasal sprays like Avamis have a lower risk of systemic side effects.

Clinical trials have demonstrated the efficacy of Avamis in improving nasal symptoms and quality of life in patients with allergic rhinitis. In a comparative study published in the American Journal of Rhinology & Allergy, Avamis was found to be as effective as other intranasal corticosteroids in relieving nasal congestion and other allergy symptoms.